IP Library Patent Application 11891120
Patent Application
App. No. 11/891,120

Methods of improving bone health and muscle health

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/891,120
Abstract

The present invention comprises a method of improving bone health and muscle health in a companion animal comprising administering a composition comprising a fatty acid component to the companion animal wherein the fatty acid component comprises a ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) from about 3:1 to about 25:1. The present invention additionally comprises a composition comprising a fatty acid component comprising docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) wherein the ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 3:1 to about 25:1.

Claims (25)

1 . A method of improving bone health and muscle health in a companion animal comprising: administering a composition comprising a fatty acid component to a companion animal; and wherein said fatty acid component comprises a ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) from about 3:1 to about 25:1.

2 . The method of claim 1 , wherein said improving bone health comprises preventing or treating the loss of bone mineral density, preventing or treating the loss of bone mineral content, or preventing or treating the loss of bone ash content or preventing or treating osteopenia; and wherein said improving muscle health comprises preventing or treating the loss of muscle fiber diameter, preventing or treating the loss of muscle mass, or preventing or treating the loss of muscle wet weight or preventing or treating muscle atrophy.

3 . The method of claim 1 , wherein docosahexaenoic acid (DHA) is from about 0.04% to about 100%, by weight of the composition.

4 . The method of claim 1 , wherein eicosapentaenoic acid (EPA) is from about 0.02% to about 40% by weight of the composition.

5 . The method of claim 1 , wherein said ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 3:1 to about 22:1.

6 . The method of claim 1 , wherein said ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 4:1 to about 21:1.

7 . The method of claim 1 , wherein said ratio of said docosahexaenoic acid (DHA) to said eicosapentaenoic acid (EPA) is from about 5:1 to about 20:1.

8 . The method of claim 1 , wherein said ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 6:1 to about 18:1.

9 . The method of claim 1 , wherein said fatty acid component further comprises an omega-6 polyunsaturated fatty acid.

10 . The method of claim 1 , wherein said composition is selected from the group consisting of wet, moist, dry, and combinations thereof.

11 . The method of claim 1 , wherein said composition is selected from the group consisting of pet food, dog food, cat food, supplements, treats, chews, beverages, sauces, pills, capsules and combinations thereof.

12 . The method of claim 11 , wherein said composition is complete and nutritionally balanced.

13 . The method of claim 1 , wherein said composition further comprises animal protein, plant protein, farinaceous matter, vegetables, fruit, egg-based materials, undenatured proteins, food grade polymeric adhesives, gels, polyols, starches, gums, flavorants, seasonings, salts, colorants, time-release compounds, delayed release compounds, site specific release compounds, minerals, vitamins, antioxidants, prebiotics, probiotics, aroma modifiers, and combinations thereof.

14 . A composition that improves bone health and muscle health in a companion animal comprising: a composition comprising a fatty acid component comprising docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA); and wherein said fatty acid component comprises a ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) from about 3:1 to about 25:1.

15 . The composition of claim 14 , wherein docosahexaenoic acid (DHA) is from about 0.04% to about 100%, by weight of the composition.

16 . The composition of claim 14 , wherein eicosapentaenoic acid (EPA) is from about 0.02% to about 40% by weight of the composition.

17 . The composition of claim 14 , wherein said ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 3:1 to about 22:1.

18 . The composition of claim 14 , wherein said ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 4:1 to about 21:1.

19 . The composition of claim 14 , wherein said ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 5:1 to about 20:1.

20 . The composition of claim 14 , wherein said ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 6:1 to about 18:1.

21 . The composition of claim 14 , wherein said fatty acid component further comprises an omega-6 polyunsaturated fatty acid.

22 . The composition of claim 14 , wherein said composition is selected from the group consisting of wet, moist, dry, and combinations thereof.

23 . The composition of claim 14 , wherein said composition is selected from the group consisting of pet food, dog food, cat food, supplements, treats, chews, beverages, sauces, pills, capsules, and combinations thereof.

24 . The composition of claim 23 , wherein said composition is complete and nutritionally balanced.

25 . The composition of claim 14 , wherein said composition further comprises animal protein, plant protein, farinaceous matter, vegetables, fruit, egg-based materials, undenatured proteins, food grade polymeric adhesives, gels, polyols, starches, gums, flavorants, seasonings, salts, colorants, time-release compounds, delayed release compounds, site specific release compounds, minerals, vitamins, antioxidants, prebiotics, probiotics, aroma modifiers, and combinations thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2015
From: THE IAMS COMPANY
To: MARS, INCORPORATED
Reel/Frame 037197/0153 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE TO THE IAMS COMPANY PREVIOUSLY RECORDED ON REEL 020229 FRAME 0665. ASSIGNOR(S) HEREBY CONFIRMS THE PROCTER & GAMBLE COMPANY. Recorded Dec 2, 2013
From: WATKINS, BRUCE ALAN; HANNON, KEVIN MARK; LEPINE, ALLAN JOHN
To: THE IAMS COMPANY
Reel/Frame 031746/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2007
From: WATKINS, BRUCE ALAN; HANNON, KEVIN MARK; LEPINE, ALLAN JOHN
To: PROCTER & GAMBLE COMPANY, THE
Reel/Frame 020229/0665 →